Tag: CLF

Blue Horseshoe Stocks: OPK, CAT & More

Opko Health, Inc. OPK

We’re going to start things off this morning by highlighting a potential bottom-bounce play in OPK which is presently boasting a ripening chart setup.

Not only that, but we’ve got a Form-4 alert on this one as well, with CEO Phillip Frost purchasing 100,000 shares yesterday at 4.89. We generally take insider buying at a bottom, especially a strong double bottom like OPK is exhibiting, as a sign that a more sustained recovery could be on the way.

We’ll place this stock on watch in the days and weeks ahead as well as keep an eye on an options idea, the OPK 03/02 $5-6 Calls.

Caterpillar Inc. CAT

Speaking of options ideas, we wanted to submit one for CAT as well in the wake of its premarket earnings release, wherein the company reported a 35% sales increase and a solid beat on profits.

The stock is gapping up into blue skies this morning in the $175 range, so we’ll be looking for a classic early dip-and-rip, and tracking the CAT Weekly $170-175 Calls for potential quick-strike trades.

Extended Watchlist:
RMGN, ATOS, CLF, MYSZ, GALT MDZ, LODE

Blue Horseshoe Stocks: INFI Review & More

Infinity Pharmaceuticals, Inc. INFI

The stock with the most notable performance from yesterday morning’s watchlist was definitely INFI, which began trending up in the premarket, and continued its climb throughout the entire session.

The stock traded up from a low of 2.44 to 3.75, which works out to an intraday rise of 54% and it came on roughly 38X its monthly average volume. An early pullback from profit taking this morning would be a likely scenario, but if INFI can find support at a higher point than yesterday’s low, from


AcelRx Pharmaceuticals, Inc. ACRX

After the FDA’s rejecion of the company’s ‘Dsuvia” opioid painkiller, ACRX took a monstrous pounding yesterday down to its lowest price in three months.

As you can see on the chart, it fell all the way down to an area of support it had established back in July. We’ll be interested to monitor this play for a bottom, which could come at any time. Moves generated by FDA news, whether positive or negative, tend to be over-exaggerated and are almost always followed by a course correction.

Inotek Pharmaceuticals Corp ITEK

Here we have an example of being extremely ‘early to the party’ as we sometimes say. We alerted on ITEK back in July, after which point it saw a low of .89. It mostly traded sideways throughout the remainder of the summer, but recently began quite an impressive climb.

This morning, the stock hit news highs of 4.15 in premarket trading on news of a proposed merger with a clinical stage gene therapy company. It may have took a few months to realize, but it works out to an increase of 366%

For an added angle going forward, we’ll also signal the ITEK 10/20 $2.50 Calls for possible daytrades and/or swing trades into next week, and the 11/17 $2.50 & $5.00 Calls for a longer term idea.

Extended Watchlist:
SONS, MARK, HSC, DPW, AKS, CLF, RIG, ATNM, MGEN

Blue Horseshoe Stocks: Fresh Options Ideas & More

DSW Inc. DSW

In terms of things we routinely look for in stocks that we set our sights upon, DSW seems to currently have a lot to offer. It’s a stock that has just registered a new annual low, while rapidly approaching heavily oversold territory according to indicators on the chart.

The company also happens to have released its quarterly earnings this morning, the results of which exceeded expectations as DSW recorded its first same-store sales increases since 2015.

With all these things going for it, it seems only logical for us to formulate an options idea to put on our radars and monitor over the next few weeks. We’re going to have our eye on the DSW 09/15 $17.50 & $20 Calls.

Zion Oil & Gas, Inc. ZN

We’ve spotted a nice chart setup on ZN as well on our routine morning scan today. We’ve pointed that out on the chart below.

The stock had a really nice run back in June that carried it from the 1.40 area up to $7, and after consolidating off of those highs during the past several weeks, it seems to have found support and begun its next up-cycle.

Hypothetically, a return to the highs it saw earlier in the summer, would mean more than a double-bagger from current pricing.

Extended Watchlist:
ARCI, F, CLF, MTBC, FALC, WATT